BamSEC and AlphaSense Join Forces
Learn More

Idenix Pharmaceuticals Inc

Formerly NASDAQ: IDIX
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 6 pages Third Amendment to Lease
12/34/56
EX-10.1
from 8-K 13 pages November 23, 2010 Confidential Paul Fanning 17 Stable Way Medway, Ma 02053 Dear Paul: This Restatement to Your Employment Letter of February 24, 2004, Is Made This 23rd Day of November, 2010 Between You and Idenix Pharmaceuticals, Inc., a Corporation Incorporated Under the Laws of the State of Delaware (Together With Its Successors and Assigns, the “Company”)
12/34/56
EX-10.46
from 10-K 8 pages September 9, 2013 David Standring 205 Gun Hill Street Milton, Ma 02186 Dear David
12/34/56
EX-10.2
from 8-K 7 pages Baupost Capital, L.L.C. 10 St. James Avenue, Suite 1700 Boston, Ma 0211 January 27, 2014
12/34/56
EX-10.1
from 8-K 15 pages January 27, 2014 Idenix Pharmaceuticals, Inc. 320 Bent Street Cambridge, Massachusetts 02141-2025 Ladies and Gentlemen: Each of the Undersigned (Each, an “Investor” and Collectively, the “Investors”) Hereby Confirms and Agrees, Severally and Not Jointly, With You as Follows: 1. This Purchase Agreement (Together With the Attached Schedule and Annexes, the “Agreement”) Is Made as of the Date Hereof Between Idenix Pharmaceuticals, Inc., a Delaware Corporation (The “Company”), and Each Investor That Is a Signatory to This Agreement
12/34/56
EX-10.1
from 8-K 16 pages December 30, 2013 Confidential Jacques Dumas 32 Suffolk Lane Carlisle, Ma 01741 Dear Jacques
12/34/56
EX-10.1
from 10-Q 5 pages Second Amendment to Lease
12/34/56
EX-10.2
from 10-Q 2 pages First Amendment to Clinical Trial Collaboration Agreement Between Idenix Pharmaceuticals, Inc. and Janssen Pharmaceuticals, Inc.,
12/34/56
EX-10.1
from 10-Q 5 pages First Amendment to Lease
12/34/56
EX-10.24
from 10-K 74 pages Recitals Article 1 Definitions
12/34/56
EX-10.2
from 8-K 5 pages Lease Termination Agreement
12/34/56
EX-10.1
from 8-K 67 pages Lease by and Between Bmr-Rogers Street LLC, a Delaware Limited Liability Company and Idenix Pharmaceuticals, Inc., a Delaware Corporation Lease
12/34/56
EX-10.4
from 10-Q 61 pages Termination and Revised Relationship Agreement
12/34/56
EX-10.3
from 10-Q 4 pages Idenix Pharmaceuticals, Inc. Nonstatutory Stock Option Agreement Granted Under 2012 Stock Incentive Plan
12/34/56
EX-10.2
from 10-Q 4 pages Idenix Pharmaceuticals, Inc. Incentive Stock Option Agreement Granted Under 2012 Stock Incentive Plan
12/34/56
EX-10.1
from 10-Q 17 pages Idenix Pharmaceuticals, Inc. 2012 Stock Incentive Plan
12/34/56
EX-10.1
from 8-K 29 pages Idenix Pharmaceuticals, Inc. Second Amended and Restated Stockholders’ Agreement July 31, 2012
12/34/56
EX-10.12
from 10-K 10 pages Fifth Amendment of Lease
12/34/56
EX-10.1
from 8-K 13 pages June 20, 2011 Confidential Daniella Beckman Dear Daniella: On Behalf of Idenix Pharmaceuticals, Inc. (“Idenix” or the “Company”), I Am Pleased to Offer You the Position of Vice President, Chief Financial Officer and Treasurer, Reporting Directly to Me as President and Chief Executive Officer. the Terms of Our Employment Offer Are Set Forth Below
12/34/56
EX-10.1
from 8-K 15 pages Concurrent Private Placement Stock Purchase Agreement by and Between Novartis Pharma AG and Idenix Pharmaceuticals, Inc
12/34/56